Epclusa is a prescription medication used to treat hepatitis C, a viral infection that can cause liver damage.
It is available in both brand-name and generic form, and contains the active ingredients sofosbuvir and velpatasvir.
Sofosbuvir is a nucleotide analog inhibitor that works by blocking the hepatitis C virus from replicating, while velpatasvir is a pan-genotypic inhibitor that helps to prevent the virus from attaching to and infecting liver cells.
Together, these two active ingredients can help to clear the hepatitis C virus from the body and reduce the risk of liver damage.
The generic version of Epclusa, which is also known as sofosbuvir/velpatasvir, is bio equivalent to the brand-name version, meaning that it contains the same active ingredients and is expected to work in the same way.
However, the generic version of Epclusa price is typically much less expensive than the brand-name version, making it more accessible for patients who may be unable to afford the higher price.
It’s worth noting that the generic version of Epclusa may not be available in all countries, and the availability and cost may vary depending on the specific location.
Patients should discuss the availability and cost of Epclusa with their healthcare provider and consider their own financial situation before starting treatment. In some cases, it may be possible to negotiate a lower price or to explore alternative treatment options.
Takeaway here is do whatever it takes to get the price of Epclusa down so it is affordable for your budget. If you are not able to afford the copay or even a $1000, get Epclusa here. It will save you the hassles and the headaches to deal with all the red tape just to get treated for hepatitis C.